AEM vs LXU

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

LXU exhibits a stable financial foundation with a Piotroski F-Score of 6/9, though it currently trades at a significant premium to its Graham Number ($7.45) and Intrinsic Value ($2.38). While explosive earnings growth (YoY EPS +211.1%) and a low PEG ratio (0.42) suggest strong future potential, these are heavily offset by aggressive insider selling totaling $77.79M. The disconnect between the bullish analyst consensus and the bearish insider sentiment and technical trend creates a high-risk profile despite the strong revenue growth.